Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.4185 (-0.12%) ($0.4185 - $0.4185) on Thu. Apr. 7, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.49% (three month average) | RSI | 49 | Latest Price | $0.4185(-0.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -2.3% a day on average for past five trading days. | Weekly Trend | ANPC declines -3.7% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) GLD(89%) TIP(45%) TLT(45%) GDX(35%) MCHI(35%) | Factors Impacting ANPC price | ANPC will decline at least -5.245% in a week (0% probabilities). VIXM(-24%) TBT(-21%) UNG(-10%) UUP(-9%) ARKK(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.245% (StdDev 10.49%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $0.46 | 5 Day Moving Average | $0.43(-2.67%) | 10 Day Moving Average | $0.43(-2.67%) | 20 Day Moving Average | $0.46(-9.02%) | To recent high | -67.9% | To recent low | 6.8% | Market Cap | $4m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |